Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18302747

Download in:

View as

General Info

PMID
18302747